10:36 AM
 | 
Nov 09, 2018
 |  BC Week In Review  |  Company News  |  Sales & Marketing

AZ looks to new medicines to drive growth

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Nov. 8 it will look to 10 new drugs to support a return to growth. The pharma reported 3Q18 product sales of $5.3 billion, up 9% at constant exchange rates from 3Q17 and driven by an 86% increase in new medicines and a 16% increase in emerging markets....

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >